Literature DB >> 8315933

Treatment and prevention of hyperkalemia in end-stage renal disease.

M Allon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315933     DOI: 10.1038/ki.1993.170

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  6 in total

1.  Safety of perioperative hemodialysis and continuous hemodiafiltration for dialysis patients with cardiac surgery.

Authors:  Keiji Kamohara; Masaru Yoshikai; Junji Yunoki; Hideyuki Fumoto; Junichi Murayama; Masakatsu Hamada; Tsuyoshi Itoh
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-02

2.  Hyperkalemia across the Continuum of Kidney Function.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 8.237

3.  Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol.

Authors:  M J Kemper; E Harps; H H Hellwege; D E Müller-Wiefel
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

4.  Aldosterone-receptor antagonism and end-stage renal disease.

Authors:  Niall McLaughlin; Todd W B Gehr; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

5.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22

Review 6.  Potassium homeostasis and its disturbances in children.

Authors:  J Rodríguez-Soriano
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.